Animal Vaccines Market - Global Professional Analysis and Forecast to 2026

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The worldwide Animal Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.8% during the forecast period.

    This report presents the market size and development trends by detailing the Animal Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Animal Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Animal Vaccines industry and will help you to build a panoramic view of the industrial development.

    Animal Vaccines Market, By Type:

    • Killed Vaccines

    • Modified Live Vaccines

    • Recombinant Vaccines

    Animal Vaccines Market, By Application:

    • Pet

    • Poultry

    • Other

    Some of the leading players are as follows:

    • 3M

    • Novartis

    • Zoetis

    • Boehringer Ingelheim

    • Pfizer

    • Bayer HealthCare

    • Ceva

    • Johnson & Johnson

    • Lomir Biomedical

    • Sanofi-Aventis

    • Virbac

    • Bioniche Animal Health Canada, Inc.

    • MedFly

    • R M Hatcheries

    • R. M. Hatcheries

    • Merck

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

    • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Animal Vaccines Market: Technology Type Analysis

    • 4.1 Animal Vaccines Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Animal Vaccines Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Killed Vaccines

      • 4.3.2 Modified Live Vaccines

      • 4.3.3 Recombinant Vaccines

    5 Animal Vaccines Market: Product Analysis

    • 5.1 Animal Vaccines Product Market Share Analysis, 2018 & 2026

    • 5.2 Animal Vaccines Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Animal Vaccines Market: Application Analysis

    • 6.1 Animal Vaccines Application Market Share Analysis, 2018 & 2026

    • 6.2 Animal Vaccines Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 Pet

      • 6.3.2 Poultry

      • 6.3.3 Other

    7 Animal Vaccines Market: Regional Analysis

    • 7.1 Animal Vaccines Regional Market Share Analysis, 2018 & 2026

    • 7.2 Animal Vaccines Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 3M

      • 9.1.1 3M Company overview

      • 9.1.2 Financial performance

      • 9.1.3 Product benchmarking

      • 9.1.4 Strategic initiatives

      • 9.1.5 SWOT analysis

    • 9.2 Novartis

      • 9.2.1 Novartis Company overview

      • 9.2.2 Financial performance

      • 9.2.3 Product benchmarking

      • 9.2.4 Strategic initiatives

      • 9.2.5 SWOT analysis

    • 9.3 Zoetis

      • 9.3.1 Zoetis Company overview

      • 9.3.2 Financial performance

      • 9.3.3 Product benchmarking

      • 9.3.4 Strategic initiatives

      • 9.3.5 SWOT analysis

    • 9.4 Boehringer Ingelheim

      • 9.4.1 Boehringer Ingelheim Company overview

      • 9.4.2 Financial performance

      • 9.4.3 Product benchmarking

      • 9.4.4 Strategic initiatives

      • 9.4.5 SWOT analysis

    • 9.5 Pfizer

      • 9.5.1 Pfizer Company overview

      • 9.5.2 Financial performance

      • 9.5.3 Product benchmarking

      • 9.5.4 Strategic initiatives

      • 9.5.5 SWOT analysis

    • 9.6 Bayer HealthCare

      • 9.6.1 Bayer HealthCare Company overview

      • 9.6.2 Financial performance

      • 9.6.3 Product benchmarking

      • 9.6.4 Strategic initiatives

      • 9.6.5 SWOT analysis

    • 9.7 Ceva

      • 9.7.1 Ceva Company overview

      • 9.7.2 Financial performance

      • 9.7.3 Product benchmarking

      • 9.7.4 Strategic initiatives

      • 9.7.5 SWOT analysis

    • 9.8 Johnson & Johnson

      • 9.8.1 Johnson & Johnson Company overview

      • 9.8.2 Financial performance

      • 9.8.3 Product benchmarking

      • 9.8.4 Strategic initiatives

      • 9.8.5 SWOT analysis

    • 9.9 Lomir Biomedical

      • 9.9.1 Lomir Biomedical Company overview

      • 9.9.2 Financial performance

      • 9.9.3 Product benchmarking

      • 9.9.4 Strategic initiatives

      • 9.9.5 SWOT analysis

    • 9.10 Sanofi-Aventis

      • 9.10.1 Sanofi-Aventis Company overview

      • 9.10.2 Financial performance

      • 9.10.3 Product benchmarking

      • 9.10.4 Strategic initiatives

      • 9.10.5 SWOT analysis

    • 9.11 Virbac

      • 9.11.1 Virbac Company overview

      • 9.11.2 Financial performance

      • 9.11.3 Product benchmarking

      • 9.11.4 Strategic initiatives

      • 9.11.5 SWOT analysis

    • 9.12 Bioniche Animal Health Canada, Inc.

      • 9.12.1 Bioniche Animal Health Canada, Inc. Company overview

      • 9.12.2 Financial performance

      • 9.12.3 Product benchmarking

      • 9.12.4 Strategic initiatives

      • 9.12.5 SWOT analysis

    • 9.13 MedFly

      • 9.13.1 MedFly Company overview

      • 9.13.2 Financial performance

      • 9.13.3 Product benchmarking

      • 9.13.4 Strategic initiatives

      • 9.13.5 SWOT analysis

    • 9.14 R M Hatcheries

      • 9.14.1 R M Hatcheries Company overview

      • 9.14.2 Financial performance

      • 9.14.3 Product benchmarking

      • 9.14.4 Strategic initiatives

      • 9.14.5 SWOT analysis

    • 9.15 R. M. Hatcheries

      • 9.15.1 R. M. Hatcheries Company overview

      • 9.15.2 Financial performance

      • 9.15.3 Product benchmarking

      • 9.15.4 Strategic initiatives

      • 9.15.5 SWOT analysis

    • 9.16 Merck

      • 9.16.1 Merck Company overview

      • 9.16.2 Financial performance

      • 9.16.3 Product benchmarking

      • 9.16.4 Strategic initiatives

      • 9.16.5 SWOT analysis

     

    The List of Tables and Figures (Totals 101 Figures and 153 Tables)

    • Figure Killed Vaccines Animal Vaccines market, 2015 - 2026 (USD Million)

    • Figure Modified Live Vaccines Animal Vaccines market, 2015 - 2026 (USD Million)

    • Figure Recombinant Vaccines Animal Vaccines market, 2015 - 2026 (USD Million)

    • Figure Pet market, 2015 - 2026 (USD Million)

    • Figure Poultry market, 2015 - 2026 (USD Million)

    • Figure Other market, 2015 - 2026 (USD Million)

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Animal Vaccines market, by country, 2015 - 2026 (USD Million)

    • Table North America Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table North America Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table North America Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Canada Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Canada Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Europe Animal Vaccines market, by country, 2015 - 2026 (USD Million)

    • Table Europe Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Europe Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Europe Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Germany Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Germany Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table France Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table France Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Italy Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Italy Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Spain Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Spain Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Animal Vaccines market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table China Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table China Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Japan Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Japan Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table India Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table India Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Animal Vaccines market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table MEA Animal Vaccines market, by country, 2015 - 2026 (USD Million)

    • Table MEA Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table MEA Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table MEA Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Animal Vaccines market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Animal Vaccines market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Animal Vaccines market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Company Profiles

    • Table 3M Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Novartis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Zoetis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Boehringer Ingelheim Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Pfizer Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bayer HealthCare Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Ceva Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Johnson & Johnson Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Lomir Biomedical Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Sanofi-Aventis Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Virbac Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Bioniche Animal Health Canada, Inc. Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table MedFly Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table R M Hatcheries Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table R. M. Hatcheries Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

    • Table Company Profiles

    • Table Merck Production, Value, Price, Gross Margin 2014-2019

    • Table Product benchmarking

    • Table Strategic initiatives

    • Table SWOT analysis

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.